**Question:** Asherman's syndrome can be diagnosed by all except:

A. Transvaginal ultrasound
B. Hysterosalpingogram (HSG)
C. Serum hormone levels
D. Cervical mucus analysis

**Core Concept:** Asherman's syndrome is a condition characterized by partial or complete destruction of the endometrium and myometrium, leading to narrowing or obliteration of the uterine cavity. It is often caused by iatrogenic factors, such as repeated dilation and curettage (D&C), prolonged use of intrauterine devices (IUDs), or pelvic infections. These injuries lead to scarring and fibrosis, disrupting the normal menstrual cycle and impairing fertility.

**Why the Correct Answer is Right:** Cervical mucus analysis (D) is not a diagnostic tool for Asherman's syndrome, as it assesses the quality and quantity of cervical mucus but does not evaluate the structural changes in the uterine cavity. Serum hormone levels (C) also do not diagnose Asherman's syndrome directly, as they merely indicate hormonal status rather than assessing the uterine cavity.

Hysterosalpingogram (HSG) (B) is a diagnostic test that involves injecting a contrast agent into the uterus and X-raying the pelvis to evaluate the uterine cavity and fallopian tubes. While HSG can detect structural abnormalities, it does not specifically assess the degree of uterine cavity involvement in Asherman's syndrome. Transvaginal ultrasound (A) is a valuable imaging tool for evaluating the uterine cavity and is often used to diagnose Asherman's syndrome. It can visualize the uterine cavity, assess endometrial thickness, and identify any scarring or adhesions.

**Why Each Wrong Option is Incorrect:**

Transvaginal ultrasound (A) is a crucial diagnostic tool for evaluating uterine cavity abnormalities, including those seen in Asherman's syndrome. Assessing the uterine cavity, endometrial thickness, and identifying scarring or adhesions are key components of ultrasound examination in this context.

Hysterosalpingogram (HSG) is a diagnostic test used to evaluate the reproductive system, particularly to check for tubal patency and assess the uterine cavity. However, it does not specifically evaluate the degree of uterine cavity involvement in Asherman's syndrome.

Serum hormone levels (C) provide information about hormonal status but do not directly assess the uterine cavity or determine the severity of Asherman's syndrome.

Cervical mucus analysis (D) is a test that evaluates cervical mucus quality and quantity but does not directly assess the uterine cavity or diagnose Asherman's syndrome.

**Clinical Pearl:** A comprehensive diagnostic workup for Asherman's syndrome should include transvaginal ultrasound and HSG, as well as a detailed clinical history and physical examination. In some cases, endometrial biopsy and hysterosalpingography (HSG) may be necessary to confirm the diagnosis and evaluate tubal patency.